Skip to content
10-Q

Quarterly Report

ASTEX PHARMACEUTICALS, INC

0001047469-12-008047

← back to feed
Filed
Aug 9, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 3, 2012 93.29M sh
Stockholders Equity Q2 2012 · Jun 30, 2012 $228.4M
Stockholders Equity Q2 2012 · Dec 31, 2011 $220M
Current Liabilities Q2 2012 · Jun 30, 2012 $19.21M
Current Liabilities Q2 2012 · Dec 31, 2011 $34.67M
Total Liabilities Q2 2012 · Jun 30, 2012 $40.91M
Total Liabilities Q2 2012 · Dec 31, 2011 $56.95M
Current Assets Q2 2012 · Jun 30, 2012 $132.06M
Current Assets Q2 2012 · Dec 31, 2011 $136.57M
Total Assets Q2 2012 · Jun 30, 2012 $269.31M
Total Assets Q2 2012 · Dec 31, 2011 $276.95M
Shares Diluted Q2 2012 · Jun 30, 2011 61.07M sh
Shares Diluted Q2 2012 · Jun 30, 2011 61.04M sh
Capex Q2 2012 · Jun 30, 2011 $528K
Cash And Equivalents Q2 2012 · Jun 30, 2011 $30.03M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $25.55M
Eps Diluted Q2 2012 · Jun 30, 2011 $0.01
Eps Diluted Q2 2012 · Jun 30, 2011 $0.10
Eps Basic Q2 2012 · Jun 30, 2011 $0.01
Eps Basic Q2 2012 · Jun 30, 2011 $0.11
Sga Expense Q2 2012 · Jun 30, 2011 $3.53M
Sga Expense Q2 2012 · Jun 30, 2011 $7.15M
Rd Expense Q2 2012 · Jun 30, 2011 $7.99M
Rd Expense Q2 2012 · Jun 30, 2011 $15.99M
Operating Income Q2 2012 · Jun 30, 2011 $842K
Operating Income Q2 2012 · Jun 30, 2011 $6.33M
Revenue Q2 2012 · Jun 30, 2011 $11.67M
Revenue Q2 2012 · Jun 30, 2011 $28.76M